School of Nursing, Umm Al-Qura University, Makkah, Saudi Arabia.
School of Nursing, Faculty of Health, Queensland University of Technology, Brisbane, Australia.
Trials. 2022 Dec 2;23(1):972. doi: 10.1186/s13063-022-06908-3.
BACKGROUND: More than 2.5 million people are admitted for surgery in Australia each year, and between 40 to 80% will experience moderate to high preoperative anxiety. Elevated levels of preoperative anxiety can increase the risk of postoperative complications such as pain, delayed wound healing, infection, prolonged recovery, and longer hospitalisation. Limited previous research on Virtual Reality (VR) indicates a positive impact on surgery-related anxiety and suggests that the intervention potentially leads to reduce postoperative complications. OBJECTIVE: To evaluate the effectiveness of using VR technology for perioperative anxiety among adults undergoing elective surgery. METHOD: A two-group parallel randomised controlled trial (RCT) will be conducted, including 150 adult patients (aged 18 years and over) undergoing elective surgery and requiring an overnight stay at a major metropolitan hospital. Eligible participants will be screened for anxiety via the Amsterdam Preoperative Anxiety and Information score (APAIS). Those with moderate to severe anxiety will be randomly allocated to receive the VR session or usual care, in the preoperative holding area. Intervention participants will use a head-mounted VR device to watch and listen to a nature scene for 10 minutes. STUDY OUTCOMES: The primary outcome is perioperative anxiety measured using the visual analogue scale for anxiety (VAS-A). Secondary outcomes include stress levels (measured by saliva cortisol level and heart rate), postoperative pain, patient satisfaction with perioperative care, hospital length of stay, and VR-associated adverse events. CONCLUSION: This study will help evaluate if a brief preoperative VR session can reduce perioperative anxiety for adult elective surgical patients. TRIAL REGISTRATION: Australia and New Zealand Clinical Trials Registry (ANZCTR) ACTRN12620001350910.
背景:澳大利亚每年有超过 250 万人接受手术治疗,其中 40%至 80%的人会经历中度至高度的术前焦虑。术前焦虑水平升高会增加术后并发症的风险,如疼痛、伤口愈合延迟、感染、恢复时间延长和住院时间延长。先前对虚拟现实(VR)的有限研究表明,其对手术相关焦虑有积极影响,并表明该干预措施可能会降低术后并发症的发生。
目的:评估 VR 技术在缓解择期手术成人围手术期焦虑中的效果。
方法:将进行一项两臂平行随机对照试验(RCT),纳入 150 名成年择期手术且需在大都市医院过夜的患者(年龄 18 岁及以上)。将使用阿姆斯特丹术前焦虑和信息评分(APAIS)对有焦虑症的合格参与者进行焦虑筛查。中度至重度焦虑的参与者将在术前等候区随机分配接受 VR 治疗或常规护理。干预组参与者将使用头戴式 VR 设备观看和聆听 10 分钟的自然场景。
研究结果:主要结局是使用焦虑视觉模拟量表(VAS-A)测量围手术期焦虑。次要结局包括应激水平(通过唾液皮质醇水平和心率测量)、术后疼痛、患者对围手术期护理的满意度、住院时间和 VR 相关不良事件。
结论:本研究将有助于评估术前简短 VR 治疗是否能降低择期手术成年患者的围手术期焦虑。
试验注册:澳大利亚和新西兰临床试验注册(ANZCTR)ACTRN12620001350910。
Trials. 2019-12-27
Curr Anesthesiol Rep. 2022
Front Psychol. 2021-10-11
Indian J Psychol Med. 2020-1-6
J Stomatol Oral Maxillofac Surg. 2018-1-6